PhRMA Innovation Hub Highlights Research and Advances in the Biopharmaceutical Industry

This article outlines the current human and economic impact that cancer imposes on the U.S. and the progress that is being made toward fighting cancer and understanding the value of its therapies. Chronic Leukemias: Survival Rates Rise: The 5-year survival rate for chronic myeloid leukemia (CML) patients has increased dramatically since imatinib was first approved for treatment in 2001. Pipeline of Hope: Learn about the discovery and development process of life-saving or life-enhancing medicines, from initial research to delivery. Great Moments in Treatment Innovation highlights the key advances that have changed medicine over the last century great moments in medical innovation. In 1900, life expectancy was fifty years. Today’s life expectancy surpasses 80 years. This link walks through noteworthy breakthroughs in the past hundred years. Innovative Treatments for Rheumatoid Arthritis Improve the Lives of Patients:  Therapeutic advances have transformed treatment of rheumatoid arthritis (RA) over the last two decades, from focusing on symptom management to now aiming for slowed disease progression and even disease remission.       Related StoriesDEA Places Heavy Restrictions on Vicodin and Other Hydrocodone Combination Drugs; Gives Stakeholders 45 Days to AdjustPublic Distrust of Pharmaceutical Industry Could Harm Research and Development of Important AntibioticsPharmaceutical Adherence Programs Vital to Lowering Health Costs 
Source: Policy and Medicine - Category: American Health Authors: Source Type: blogs